The rise and fall of long-latency Plasmodium vivax
- PMID: 30809676
- PMCID: PMC6432802
- DOI: 10.1093/trstmh/trz002
The rise and fall of long-latency Plasmodium vivax
Abstract
Until World War II the only clinical phenotype of Plasmodium vivax generally recognised in medicine was one associated with either a long (8-9 months) incubation period or a similarly long interval between initial illness and the first relapse. Long-latency P. vivax 'strains' were the first in which relapse, drug resistance and pre-erythrocytic development were described. They were the infections in which primaquine radical cure dosing was developed. A long-latency 'strain' was the first to be fully sequenced. Although long-latency P. vivax is still present in some parts of Asia, North Africa and the Americas, in recent years it has been largely forgotten.
Keywords: Plasmodium vivax; long latency; malaria; relapse.
© The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
Figures


Similar articles
-
Management of relapsing Plasmodium vivax malaria.Expert Rev Anti Infect Ther. 2016 Oct;14(10):885-900. doi: 10.1080/14787210.2016.1220304. Epub 2016 Aug 31. Expert Rev Anti Infect Ther. 2016. PMID: 27530139 Free PMC article. Review.
-
[Role of primaquine in malaria control and elimination in French-speaking Africa].Bull Soc Pathol Exot. 2017 Aug;110(3):198-206. doi: 10.1007/s13149-017-0556-z. Epub 2017 Apr 17. Bull Soc Pathol Exot. 2017. PMID: 28417346 Review. French.
-
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.Drug Des Devel Ther. 2016 Jul 26;10:2387-99. doi: 10.2147/DDDT.S61443. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27528800 Free PMC article. Review.
-
Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.Am J Trop Med Hyg. 1997 Feb;56(2):231-4. doi: 10.4269/ajtmh.1997.56.231. Am J Trop Med Hyg. 1997. PMID: 9080885
-
Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.Travel Med Infect Dis. 2015 May-Jun;13(3):235-40. doi: 10.1016/j.tmaid.2014.11.005. Epub 2014 Nov 20. Travel Med Infect Dis. 2015. PMID: 25482427
Cited by
-
Profile and determinants of delayed care-seeking and diagnosis among patients with imported malaria: a retrospective study in China, 2014-2021.Infect Dis Poverty. 2022 Dec 22;11(1):125. doi: 10.1186/s40249-022-01050-3. Infect Dis Poverty. 2022. PMID: 36550586 Free PMC article.
-
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.Malar J. 2020 Jan 3;19(1):4. doi: 10.1186/s12936-019-3091-5. Malar J. 2020. PMID: 31900172 Free PMC article. Clinical Trial.
-
Tracing the origins of Plasmodium vivax resurgence after malaria elimination on Aneityum Island in Vanuatu.Commun Med (Lond). 2024 May 18;4(1):91. doi: 10.1038/s43856-024-00524-9. Commun Med (Lond). 2024. PMID: 38762604 Free PMC article.
-
Clinical impact of vivax malaria: A collection review.PLoS Med. 2022 Jan 18;19(1):e1003890. doi: 10.1371/journal.pmed.1003890. eCollection 2022 Jan. PLoS Med. 2022. PMID: 35041650 Free PMC article.
-
Plasmodium vivax severe imported malaria in two migrants in France.Malar J. 2019 Dec 16;18(1):422. doi: 10.1186/s12936-019-3067-5. Malar J. 2019. PMID: 31842880 Free PMC article.
References
-
- Yorke W, MacFie JWS. Observations on malaria made during the treatment of general paralysis. Trans R Soc Trop Med Hyg 1924;18(1–2):13–37.
-
- Wagner-Jauregg J. Die Behandlung der progressiven Paralyse und Tabes. Wien Med Wochenschr 1921;71:1105–9, 1209–15. - PubMed
-
- Snounou G, Pérignon JL. Malariotherapy—insanity at the service of malariology. Adv Parasitol 2013;81:223–55. - PubMed
-
- Yorke W. Further observations on malaria made during the treatment of general paralysis. Trans R Soc Trop Med Hyg 1926;19(3):108–22.